Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality
Autores principales: | Parish, S, Offer, A, Thompson, A, Link, E, Di Angelantonio, E, Bowman, L, Armitage, J, Danesh, J, Collins, R, Collaborati, H |
---|---|
Formato: | Journal article |
Publicado: |
2010
|
Ejemplares similares
-
Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
por: Heart Protection Study Collaborative Group
Publicado: (2010) -
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
por: Erqou, S, et al.
Publicado: (2009) -
The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
por: Kent, S, et al.
Publicado: (2016) -
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
por: Thompson, A, et al.
Publicado: (2010) -
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
por: Parish, S, et al.
Publicado: (2012)